Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws

This study investigated whether weekly teriparatide (TPTD) injections are as effective as daily teriparatide injections for the treatment of stage 3 bisphosphonate-related osteonecrosis of the jaws (BRONJ) and compared serum markers of bone turnover between the two treatment regimens. Daily TPTD treatment has recently been reported to be effective for BRONJ, but there are no reports describing the effectiveness of weekly TPTD injections. We report two patients with stage 3 BRONJ. One patient was successfully treated with weekly TPTD injections and the other with daily TPTD injections. Changes in the levels of serum N-telopeptide of type I collagen (s-NTX) and serum N-terminal propeptide of type I collagen (P1NP) were studied. Two patients with stage 3 BRONJ that was refractory to conservative treatment were treated with TPTD. Their medical records were reviewed and the patients were interviewed. There was complete mucosal coverage of the intraoral defects after 3 months of TPTD treatment in both patients. Progressive bone regeneration in an area of mandibular fracture was identified after 4 months of treatment. The s-NTX level increased slightly in both patients. This is the first report of successful treatment of stage 3 BRONJ with weekly TPTD injections. Either daily or weekly TPTD injections may effectively treat stage 3 BRONJ and should be considered before or perhaps even in lieu of undertaking major resection and reconstruction.

Nonlinear and adiabatic control of high-Q photonic crystal nanocavities

This article overviews our recent studies of ultrahigh-Q and ultrasmall photonic-crystal cavities, and their applications to nonlinear optical processing and novel adiabatic control of light. First, we show our latest achievements of ultrahigh-Q photonic-crystal nanocavities, and present extreme slow-light demonstration. Next, we show all-optical bistable switching and memory operations based on enhanced optical nonlinearity in these nanocavities with extremely low power, and discuss their applicability for realizing chip-scale all-optical logic, such as flip-flop. Finally, we introduce adiabatic tuning of high-Q nanocavities, which leads to novel wavelength conversion and another type of optical memories.

Waveguides, resonators and their coupled elements in photonic crystal slabs

The design, fabrication, and measurement of photonic-band-gap (PBG) waveguides, resonators and their coupled elements in two-dimensional photonic crystal (PhC) slabs have been investigated. We have studied various loss mechanisms in PBG waveguides and have achieved a very low propagation loss (~1 dB/mm). For these waveguides, we have observed a large group delay (>100 ps) by time-domain measurement. As regards PBG resonators, we realize very high-Q and small volume resonators in PhC slabs by appropriate design. Finally, we demonstrate various forms of coupled elements of waveguides and resonators: 2-port resonant-tunneling transmission devices, 4-port channel-drop devices using the slow light mode, and 3-port channel-drop devices using the resonant-tunneling process.

Hypertension as a paraneoplastic syndrome in hepatocellular carcinoma

We report a 66-year-old man with hepatocellular carcinoma who was positive for hepatitis B surface antigen, and was hospitalized because of hypoglycemia and hypertension. His plasma renin activity was normal (2.3 ng/ml per h), but concentrations of angiotensin I (>2500 pg/ml) and II (86 pg/ml) were high. Increased angiotensin I level at sites proximal and distal from the confluence of the hepatic vein and the inferior vena cava indicated that the hypertension was provoked by overproduction of angiotensin I from the hepatocellular carcinoma. Previous reports of patients with hepatocellular carcinoma with hypertension due to abnormality of renin-angiotensin system are reviewed.

Orthovanadate stimulates cyclic guanosine monophosphate-inhibited cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads through activation of particulate myelin basic protein kinase by protein tyrosine kinase

Involvement of protein kinases in the stimulation of cGMP-inhibited cAMP phosphodiesterase (PDE) activity by orthovanadate (vanadate) was studied. When the fat pads were incubated with 2 mM vanadate or 10 nM insulin, the stimulation of myelin basic protein kinase (MBPK) activity in the particulate by vanadate reached a maximum at 60 min. In contrast, insulin showed a transient increase at 20 min. A 60-min incubation of the fat pads with vanadate stimulated all activities of protein tyrosine kinase (PTK), MBPK, and PDE in the particulate, in a similar dose-dependent manner. Amiloride, a PTK inhibitor, inhibited the stimulations of three enzymes by vanadate in a similar concentration range. Enzyme fractions, which were separated from the solubilized particulate, were subjected to the immunoblot analysis. A fraction of MBPK was identified to contain a major protein of mol wt (44K) and a minor one (42K), both of which are immunoreactive with a mitogen-activated protein kinase (MAPK) antibody. The partially purified PDE activity was stimulated by the addition of the partially purified MBPK. The further stimulation was observed with the PTK-activated MBPK. These results suggest that vanadate stimulates in part the PDE activity through the activation of the particulate MBPK, probably MAPKs, by PTK sensitive to vanadate.